Dr. Ing S Tiong (MBChB (Distinct.), MPhil, FRACP, FRCPA) is a clinical and laboratory hematologist in the Department of Pathology and Acute Leukaemia Stream at Peter MacCallum Cancer Centre and Royal Melbourne  Hospital, and an adjunct lecturer at Monash University. His main interest is in molecular hematology, in particular, MRD-directed pre-emptive therapy in AML and the understanding of resistance mechanisms associated with targeted therapies such as venetoclax.